# Weavrcare

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/weavrcare

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.weavr.care/
- Total disclosed funding: $3.7M
- Latest round: Series A (Dec 2, 2020)
- Investors on record: 3

## About

Weavrcare (formerly MediBloc) is a healthcare technology company focused on creating a decentralized patient data management system that enhances access to medical information for both patients and healthcare providers. Weavrcare, founded in 2017 and headquartered in Seoul, South Korea, specializes in developing a blockchain-based healthcare platform that facilitates secure patient data management. In December 2020, Weavrcare raised KRW 4 billion in series A funding from Company K Partners, IMM Investment, and Naver D2 Startup Factory. Eunsol Lee, the founder, has a background that includes previous entrepreneurial ventures. Weavrcare offers innovative solutions for healthcare data management, leveraging blockchain technology to improve patient access to their medical information. Their primary product is a decentralized platform that allows patients to control their health data while enabling healthcare providers to access and share critical information securely. This system aims to streamline healthcare delivery and improve patient outcomes by fostering better communication and data integrity among healthcare professionals.MediBloc's revenue model is based on a subscription-based approach, where healthcare institutions and providers pay for access to their blockchain healthcare platform. The pricing structure includes various tiers tailored to the specific needs of clients, which helps ensure access to comprehensive healthcare management tools. The company also engages in collaborations with healthcare organizations to enhance its service offerings. Following the KRW 4 billion funding raised in December 2020, Weavrcare plans to advance its medical information platform business significantly, aiming for a more comprehensive, patient-centered healthcare solution. The company is targeting expansion into new geographic markets, particularly throughout Asia, with plans to enter these regions by 2023. The funds will be utilized to enhance the platform's capabilities and facilitate the expansion efforts, ensuring the development of a robust infrastructure for improved patient data management.

## Funding rounds

- Series A, Dec 2, 2020, $3.7M — IMM Investment, Company K Partners, Naver D2 Startup Factory

## Investors

- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series A
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series A
- Naver D2 Startup Factory (https://capitalatlas.ai/funds/naver-d2-startup-factory) — Series A